IBDEI2L8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43927,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,43928,0)
 ;;=E10.8^^170^2109^3
 ;;^UTILITY(U,$J,358.3,43928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43928,1,3,0)
 ;;=3^Diabetes Type 1 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,43928,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,43928,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,43929,0)
 ;;=E53.8^^170^2109^28
 ;;^UTILITY(U,$J,358.3,43929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43929,1,3,0)
 ;;=3^Vitamin B Group Deficiency
 ;;^UTILITY(U,$J,358.3,43929,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,43929,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,43930,0)
 ;;=E78.5^^170^2109^17
 ;;^UTILITY(U,$J,358.3,43930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43930,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,43930,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,43930,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,43931,0)
 ;;=E66.9^^170^2109^26
 ;;^UTILITY(U,$J,358.3,43931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43931,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,43931,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,43931,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,43932,0)
 ;;=E66.01^^170^2109^24
 ;;^UTILITY(U,$J,358.3,43932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43932,1,3,0)
 ;;=3^Morbid Obesity d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,43932,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,43932,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,43933,0)
 ;;=E66.3^^170^2109^27
 ;;^UTILITY(U,$J,358.3,43933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43933,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,43933,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,43933,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,43934,0)
 ;;=D50.9^^170^2109^19
 ;;^UTILITY(U,$J,358.3,43934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43934,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,43934,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,43934,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,43935,0)
 ;;=D64.9^^170^2109^2
 ;;^UTILITY(U,$J,358.3,43935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43935,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,43935,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,43935,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,43936,0)
 ;;=D68.318^^170^2109^16
 ;;^UTILITY(U,$J,358.3,43936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43936,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag,Antib,Inhib
 ;;^UTILITY(U,$J,358.3,43936,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,43936,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,43937,0)
 ;;=R50.9^^170^2109^15
 ;;^UTILITY(U,$J,358.3,43937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43937,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,43937,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,43937,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,43938,0)
 ;;=R53.81^^170^2109^22
 ;;^UTILITY(U,$J,358.3,43938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43938,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,43938,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,43938,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,43939,0)
 ;;=R53.83^^170^2109^14
 ;;^UTILITY(U,$J,358.3,43939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43939,1,3,0)
 ;;=3^Fatigue
 ;;^UTILITY(U,$J,358.3,43939,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,43939,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,43940,0)
 ;;=R60.0^^170^2109^12
 ;;^UTILITY(U,$J,358.3,43940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43940,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,43940,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,43940,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,43941,0)
 ;;=R60.1^^170^2109^11
 ;;^UTILITY(U,$J,358.3,43941,1,0)
 ;;=^358.31IA^4^2
